Analysis of the duration of combination therapy that is necessary for hepatitis C (HCV) genotype 1 eradication
| ISRCTN | ISRCTN56141572 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN56141572 |
| Protocol serial number | N0263132921 |
| Sponsor | Department of Health |
| Funder | University College London Hospitals NHS Trust (UK) |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 18/07/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr N V Naoumov
Scientific
Scientific
General Medicine (Hepatology)
Institute of Hepatology
University College London
69-75 Chenies Mews
London
WC1E 6HX
United Kingdom
| Phone | +44 (0)20 7388 2013 |
|---|---|
| n.naoumov@ucl.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Analysis of the duration of combination therapy that is necessary for hepatitis C (HCV) genotype 1 eradication |
| Study objectives | What is the duration of combination therapy required in order to produce a sustained viral clearance in hepatitis C infected patients |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Infections and Infestations: Hepatitis C |
| Intervention | Randomised Controlled Trial 1. Chemotherapy 1 2. Chemotherapy 2 |
| Intervention type | Drug |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | |
| Primary outcome measure(s) |
Viral clearance |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/10/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | All |
| Target sample size at registration | 50 |
| Key inclusion criteria | 50 patients from Hepatology |
| Key exclusion criteria | Does not match inclusion criteria |
| Date of first enrolment | 01/10/2003 |
| Date of final enrolment | 01/10/2005 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
University College London
London
WC1E 6HX
United Kingdom
WC1E 6HX
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
18/07/2016: No publications found, verifying study status with principal investigator.
